Keywords: Allergan, Botox, Overactive bladder, NuPathe, Zecuity, Migaine, USA, FDA, OAB

FDA approves Allergan's Botox for OAB and NuPathe's Zecuity for migraine

Article | 21 January 2013

Print This

US drugmaker Allergan (NYSE: AGN) says that the US Food and Drug Administration has approved its Botox (onabotulinumtoxinA), best known ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in